Page last updated: 2024-08-21

glycerylphosphorylcholine and Cancer of Ovary

glycerylphosphorylcholine has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bode, AM; Cao, Y; Li, X; Li, Z; Luo, X; Quan, J; Tan, Y	1

Other Studies

1 other study(ies) available for glycerylphosphorylcholine and Cancer of Ovary

Article	Year
DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism. Cell death & disease, 2022, 10-03, Volume: 13, Issue:10 Topics: Carbonyl Reductase (NADPH); Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Choline; Choline Kinase; Down-Regulation; Female; Glycerylphosphorylcholine; Humans; NAD; NADP; Ovarian Neoplasms; Oxidoreductases; Phosphorylcholine; Proto-Oncogene Proteins c-akt	2022

Article

Year

DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism.

Cell death & disease, 2022, 10-03, Volume: 13, Issue:10

Topics: Carbonyl Reductase (NADPH); Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Choline; Choline Kinase; Down-Regulation; Female; Glycerylphosphorylcholine; Humans; NAD; NADP; Ovarian Neoplasms; Oxidoreductases; Phosphorylcholine; Proto-Oncogene Proteins c-akt

2022